Galectin Therapeutics Shares Outstanding 2006-2018 | GALT

Galectin Therapeutics shares outstanding from 2006 to 2018. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Galectin Therapeutics Annual Shares Outstanding
(Millions of Shares)
2018 39
2017 36
2016 29
2015 24
2014 22
2013 17
2012 15
2011 12
2010 9
2009 8
2008 8
2007 7
2006 5
2005 5
Galectin Therapeutics Quarterly Shares Outstanding
(Millions of Shares)
Q4 2018 39
Q3 2018 41
Q2 2018 38
Q1 2018 37
Q4 2017 36
Q3 2017 35
Q2 2017 35
Q1 2017 34
Q4 2016 29
Q3 2016 29
Q2 2016 29
Q1 2016 29
Q4 2015 24
Q3 2015 24
Q2 2015 24
Q1 2015 23
Q4 2014 22
Q3 2014 22
Q2 2014 22
Q1 2014 20
Q4 2013 17
Q3 2013 17
Q2 2013 16
Q1 2013 16
Q4 2012 16
Q3 2012 16
Q2 2012 16
Q1 2012 13
Q4 2011 13
Q3 2011 12
Q2 2011 12
Q1 2011 11
Q4 2010 10
Q3 2010 10
Q2 2010 9
Q1 2010 8
Q4 2009 8
Q3 2009 8
Q2 2009 8
Q1 2009 8
Q4 2008 8
Q3 2008 7
Q2 2008 9
Q1 2008 7
Q4 2007 11
Q3 2007 7
Q2 2007 7
Q1 2007 6
Q4 2006 4
Q3 2006 4
Q2 2006 3
Q1 2006 5
Q4 2005 4
Q3 2005 5
Q2 2005 5
Q1 2005 5
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.198B $0.000B
Galectin Therapeutics Inc. is a drug development company engaged in the development new therapies for fibrotic disease and cancer. The Company uses its carbohydrate technology that targets galectin proteins, the key mediators of biologic and pathologic function. Galectin Therapeutics uses naturally occurring carbohydrate polymers with galactose residues to create complex carbohydrates with specific molecular weights. Galectin Therapeutics, formerly known as Pro-Pharmaceuticals, Inc. is headquartered in Newton, Massachusetts.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $47.525B 31.58
Takeda Pharmaceutical (TAK) Japan $29.622B 10.96
Grifols (GRFS) Spain $13.373B 16.34
Ionis Pharmaceuticals (IONS) United States $11.526B 35.74
Sage Therapeutics (SAGE) United States $7.914B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $7.754B 11.10
Neurocrine Biosciences (NBIX) United States $7.693B 498.29
Catalent (CTLT) United States $6.198B 25.95
Nektar Therapeutics (NKTR) United States $5.812B 9.27
United Therapeutics (UTHR) United States $4.678B 7.96
Tilray (TLRY) United States $4.673B 0.00
FibroGen (FGEN) United States $4.151B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.150B 13.36
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $4.086B 0.00
Portola Pharmaceuticals (PTLA) United States $2.315B 0.00
PTC Therapeutics (PTCT) United States $2.202B 0.00
USANA Health Sciences (USNA) United States $1.968B 16.51
Aerie Pharmaceuticals (AERI) United States $1.938B 0.00
Heron Therapeutics (HRTX) United States $1.840B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.813B 0.00
Madrigal Pharmaceuticals (MDGL) United States $1.811B 0.00
Xencor (XNCR) United States $1.802B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.781B 22.18
Ironwood Pharmaceuticals (IRWD) United States $1.754B 0.00
Endo (ENDP) Ireland $1.688B 2.60
Zogenix (ZGNX) United States $1.611B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.572B 136.14
Tricida (TCDA) United States $1.436B 0.00
Corcept Therapeutics (CORT) United States $1.351B 19.63
Theravance Biopharma (TBPH) Cayman Islands $1.289B 0.00
Esperion Therapeutics (ESPR) United States $1.117B 0.00
Spectrum Pharmaceuticals (SPPI) United States $1.116B 0.00
TherapeuticsMD (TXMD) United States $1.051B 0.00
Radius Health (RDUS) United States $1.041B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.919B 0.00
Akebia Therapeutics (AKBA) United States $0.835B 0.00
ChemoCentryx (CCXI) United States $0.746B 0.00
ArQule (ARQL) United States $0.725B 0.00
CannTrust Holdings (CTST) Canada $0.723B 0.00
Odonate Therapeutics (ODT) United States $0.640B 0.00
Dermira (DERM) United States $0.636B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.590B 0.00
Forty Seven (FTSV) United States $0.586B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.569B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.565B 0.00
GlycoMimetics (GLYC) United States $0.532B 0.00
Translate Bio (TBIO) United States $0.508B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.484B 25.00
Collegium Pharmaceutical (COLL) United States $0.481B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.465B 0.00
TCR2 THERAPTCS (TCRR) United States $0.440B 0.00
KalVista Pharmaceuticals (KALV) United States $0.436B 0.00
Siga Technologies (SIGA) United States $0.429B 0.00
OptiNose (OPTN) United States $0.418B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.415B 0.00
ImmunoGen (IMGN) United States $0.405B 0.00
Flexion Therapeutics (FLXN) United States $0.401B 0.00
Aptorum Group (APM) China $0.392B 0.00
Mast Therapeutics (SVRA) United States $0.325B 0.00
CASI Pharmaceuticals (CASI) United States $0.314B 0.00
Karyopharm Therapeutics (KPTI) United States $0.311B 0.00
Harpoon Therapy (HARP) United States $0.310B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.298B 11.02
Lannett Co Inc (LCI) United States $0.292B 2.72
Minerva Neurosciences (NERV) United States $0.285B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.266B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.265B 0.00
Opexa Therapeutics (ACER) United States $0.258B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.258B 0.00
Xeris Pharmaceuticals (XERS) United States $0.258B 0.00
Calithera Biosciences (CALA) United States $0.247B 0.00
Dova Pharmaceuticals (DOVA) United States $0.242B 0.00
Concert Pharmaceuticals (CNCE) United States $0.236B 0.00
Molecular Templates (MTEM) United States $0.233B 0.00
Aclaris Therapeutics (ACRS) United States $0.227B 0.00
Ardelyx (ARDX) United States $0.227B 0.00
Affimed (AFMD) Germany $0.223B 0.00
MEI Pharma (MEIP) United States $0.217B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.216B 0.00
Aldeyra Therapeutics (ALDX) United States $0.206B 0.00
Jounce Therapeutics (JNCE) United States $0.204B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.203B 0.00
Rafael Holdings (RFL) United States $0.202B 0.00
IMV INC (IMV) Canada $0.189B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.187B 0.00
Taiwan Liposome, Unsponsored ADR (TLC) Taiwan $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.184B 191.40
Recro Pharma (REPH) United States $0.184B 0.00
Majesco Entertainment (PTE) United States $0.183B 0.00
Redhill Biopharma (RDHL) Israel $0.181B 0.00
Aratana Therapeutics (PETX) United States $0.179B 0.00
Neon Therapeutics (NTGN) United States $0.176B 0.00
ElectroCore (ECOR) United States $0.173B 0.00
Tyme Technologies (TYME) United States $0.172B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.172B 0.00
AgeX Therapeutics (AGE) United States $0.170B 0.00
Ocular Therapeutix (OCUL) United States $0.158B 0.00
Aquestive Therapeutics (AQST) United States $0.153B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.152B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.150B 0.00
China SXT Pharmaceuticals (SXTC) China $0.140B 0.00
MediWound (MDWD) Israel $0.120B 0.00
Iterum Therapeutics (ITRM) Ireland $0.119B 0.00
Cardiome Pharma (CORV) Canada $0.112B 0.00
Neos Therapeutics (NEOS) United States $0.105B 0.00
ProNAi Therapeutics (SRRA) Canada $0.103B 0.00
Nivalis Therapeutics (ALPN) United States $0.103B 0.00
Zafgen (ZFGN) United States $0.101B 0.00
DURECT (DRRX) United States $0.097B 0.00
Natural Alternatives (NAII) United States $0.096B 9.41
Champions Oncology (CSBR) United States $0.095B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.094B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.093B 0.00
Bio Blast Pharma (ENLV) Israel $0.093B 0.00
Infinity Pharmaceuticals (INFI) United States $0.093B 0.00
Adherex Technologies (FENC) United States $0.093B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.092B 0.00
SCYNEXIS (SCYX) United States $0.088B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.084B 0.00
Otonomy (OTIC) United States $0.079B 0.00
Genocea Biosciences (GNCA) United States $0.077B 0.00
Avenue Therapeutics (ATXI) United States $0.071B 0.00
India Globalization Capital (IGC) United States $0.069B 0.00
Capnia (SLNO) United States $0.064B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.061B 0.00
CTI BioPharma (CTIC) United States $0.060B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.060B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.057B 0.00
Forward Pharma (FWP) Denmark $0.057B 0.00
Bio-Path Holdings (BPTH) United States $0.052B 0.00
Melinta Therapeutics (MLNT) United States $0.052B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.048B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.048B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.046B 0.00
KemPharm (KMPH) United States $0.045B 0.00
ContraFect (CFRX) United States $0.044B 0.00
BioLineRx (BLRX) Israel $0.043B 0.00
Lipocine (LPCN) United States $0.041B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.041B 0.00
Mannatechorporated (MTEX) United States $0.040B 0.00
Heat Biologics (HTBX) United States $0.038B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.032B 0.00
Shineco (TYHT) China $0.028B 4.73
Summit Therapeutics (SMMT) United Kingdom $0.028B 3.67
PharmAthene (ALT) United States $0.027B 0.00
IsoRay (ISR) United States $0.027B 0.00
Biomerica (BMRA) United States $0.024B 0.00
Achieve Life Sciences (ACHV) United States $0.024B 0.00
Onconova Therapeutics (ONTX) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.021B 0.00
NOVAN INC (NOVN) United States $0.021B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.020B 0.00
NanoViricides (NNVC) United States $0.020B 0.00
Pain Therapeutics (SAVA) United States $0.019B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.019B 0.00
Cyanotech (CYAN) United States $0.018B 0.00
Jaguar Animal Health (JAGX) United States $0.018B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.017B 0.00
Xenetic Biosciences (XBIO) United States $0.016B 0.00
ESSA Pharma (EPIX) Canada $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.015B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 4.17
Regulus Therapeutics (RGLS) United States $0.012B 0.00
PRECISION THERAPEUTICS INC (AIPT) United States $0.012B 0.00
Can-Fite Biopharma (CANF) Israel $0.011B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
Achaogen (AKAO) United States $0.010B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.009B 0.00
Trillium Therapeutics (TRIL) Canada $0.009B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.008B 0.00
Midatech Pharma (MTP) United Kingdom $0.007B 0.00
VAXART, INC (VXRT) United States $0.007B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.007B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00